Invesco Biotechnology & Genome ETF Rating $68.11 -0.25 (-0.37%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.71Holdings in PBE have an aggregate rating of Moderate Buy based on 452 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).PBE Aggregate Price Target$68.11High Prediction$68.11Average Prediction$68.11Low Prediction$68.11Holdings in PBE have an aggregate price target of $68.11 and a range of $68.11 to $68.11 covering 30 companies (99.9% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.03%GILDGilead Sciences$109.95-0.1%4.7853 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News5.32%NTRANatera$162.31-3.5%2.5818 of 5 stars3.00$170.94 5.3%16Positive News5.24%UTHRUnited Therapeutics$361.10-1.7%4.3677 of 5 stars2.67$388.25 7.5%12Insider TradePositive News5.08%AMGNAmgen$303.01+1.7%4.4634 of 5 stars2.46$314.09 3.7%24Insider TradePositive News4.84%INCYIncyte$72.05+0.9%4.5328 of 5 stars2.35$75.59 4.9%204.64%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7635 of 5 stars2.76$973.13 39.0%25Dividend Announcement4.37%BIIBBiogen$140.64+2.6%4.7395 of 5 stars2.43$211.85 50.6%30Analyst Forecast3.63%ILMNIllumina$94.20-3.1%4.7831 of 5 stars2.62$159.45 69.3%213.60%AXSMAxsome Therapeutics$137.75+6.7%4.5296 of 5 stars3.00$157.64 14.4%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.57%BCRXBioCryst Pharmaceuticals$9.21-1.9%3.924 of 5 stars2.83$15.50 68.3%63.41%RPRXRoyalty Pharma$33.42+0.3%4.5708 of 5 stars3.00$41.60 24.5%6Positive News3.34%HALOHalozyme Therapeutics$57.75+0.5%4.4627 of 5 stars2.60$62.78 8.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.29%ACADACADIA Pharmaceuticals$19.95-1.7%3.0693 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓2.94%CPRXCatalyst Pharmaceuticals$21.63-1.9%4.8648 of 5 stars3.11$32.25 49.1%92.83%VCYTVeracyte$39.18-4.6%2.9234 of 5 stars2.67$42.00 7.2%9Analyst DowngradeNews Coverage2.83%CDNACareDx$22.29-4.7%3.7248 of 5 stars2.57$28.33 27.1%7Upcoming EarningsAnalyst DowngradeNews Coverage2.79%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9188 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.77%BPMCBlueprint Medicines$92.25-2.2%2.9956 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade2.69%COLLCollegium Pharmaceutical$29.13-2.1%3.9883 of 5 stars2.80$43.60 49.7%5News Coverage2.67%EXELExelixis$36.85+5.0%4.6318 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider TradeGap Up2.62%MYGNMyriad Genetics$14.19-5.3%3.8395 of 5 stars2.07$22.54 58.8%14Analyst Downgrade2.58%SRPTSarepta Therapeutics$106.28-2.0%4.5034 of 5 stars2.87$176.77 66.3%23Upcoming Earnings2.53%EXASExact Sciences$49.26-0.5%4.6888 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.51%QGENQiagen$39.52+2.5%4.4452 of 5 stars2.30$47.71 20.7%10Analyst Downgrade2.49%NBIXNeurocrine Biosciences$120.69+3.9%4.9803 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up2.48%TGTXTG Therapeutics$30.88-0.2%4.4841 of 5 stars2.83$40.67 31.7%6Positive News2.45%TECHBio-Techne$64.92-0.9%4.9262 of 5 stars2.50$84.29 29.8%8Analyst DowngradeInsider Trade2.34%PTGXProtagonist Therapeutics$38.75+0.7%3.806 of 5 stars3.00$56.00 44.5%9Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up2.27%MNKDMannKind$5.77+1.9%3.0584 of 5 stars3.13$9.21 59.8%81.72%XNCRXencor$15.74-0.3%3.4815 of 5 stars3.13$34.88 121.6%8 This page (NYSEARCA:PBE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
